REBECCA GODARE STEIN: Open Payments
NPI 1033412275 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$925 in 46 payments from 14 companies in 2025. Trend: 2023 $1,248 · 2024 $1,006 · 2025 $925
Food & beverage: $925
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $184 |
| Novartis Pharmaceuticals Corporation | 9 | $152 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $117 |
| PFIZER INC. | 4 | $93 |
| Esperion Therapeutics, Inc. | 1 | $70 |
| Amgen Inc. | 4 | $66 |
| Regeneron Healthcare Solutions, Inc. | 2 | $61 |
| Kestra Medical Technology Services, Inc. | 1 | $35 |
| Boston Scientific Corporation | 1 | $35 |
| Actelion Pharmaceuticals US, Inc. | 1 | $32 |
Products named: LEQVIO, ELIQUIS, CAMZYOS, LifeVest, NEXLETOL, REPATHA, EVKEEZA, Assure WCD.
Industry payments across LA — which companies pay providers there.
